Guidance for market authorization requirements for COVID-19 drugs: Labelling and post-market requirements - Guidance for market authorization requirements for COVID-19 drugs: Labelling and post-market requirements
There are no views created for this resource yet.
Additional Information
Created | July 28, 2022 |
---|---|
Format | HTML |